Providing contraception for women taking potentially teratogenic medications: A survey of internal medicine physicians' knowledge, attitudes and barriers

Journal of General Internal Medicine

Volumn 25, Issue 4, 2010, Pages 291-297

  Eisenberg, David L ^a   Stika, Catherine ^b   Desai, Ami ^b   Baker, David ^b   Yost, Kathleen J ^c  

^a WASHINGTON UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c MAYO CLINIC   (United States)

Author keywords

Adult; Contraception; Counseling; Female; Humans; Physician behavior; Physician practice patterns; Pregnancy; Prescription drugs; Primary care; Survey; Teratogens; Women's health

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; AMPHETAMINE; CANDESARTAN; CARBAMAZEPINE; CETIRIZINE; CIPROFLOXACIN; CLOPIDOGREL; DEXAMPHETAMINE; DOXYCYCLINE; ENALAPRIL; ESCITALOPRAM; ESOMEPRAZOLE; EZETIMIBE; FLUTICASONE; LEVOFLOXACIN; LEVOTHYROXINE; LORAZEPAM; LOSARTAN; METOPROLOL; PANTOPRAZOLE; PIOGLITAZONE; RAMIPRIL; SALMETEROL; SERTRALINE; SILDENAFIL; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALSARTAN; VENLAFAXINE;

ARTICLE; CLINICAL PRACTICE; CONTRACEPTION; HEALTH BELIEF; HEALTH SURVEY; HUMAN; INTERNAL MEDICINE; PHYSICIAN ATTITUDE; PRESCRIPTION; PRIMARY MEDICAL CARE; PROFESSIONAL KNOWLEDGE; RESIDENCY EDUCATION; TERATOGENICITY; TREATMENT DURATION; TREATMENT FAILURE; URBAN AREA;

ABNORMALITIES, DRUG-INDUCED; ACADEMIC MEDICAL CENTERS; ADULT; ATTITUDE OF HEALTH PERSONNEL; CLINICAL COMPETENCE; COMMUNICATION BARRIERS; CONTRACEPTION; DIRECTIVE COUNSELING; FEMALE; HEALTH CARE SURVEYS; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNAL MEDICINE; MALE; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIANS, PRIMARY CARE; TERATOGENS; UNITED STATES; URBAN POPULATION; WOMEN'S HEALTH;

EID: 77951128417     PISSN: 08848734     EISSN: 15251497     Source Type: Journal    
DOI: 10.1007/s11606-009-1215-2     Document Type: Article

References (27)

1. J Petrini K Damus R Russell K Poschman MJ Davidoff D Mattison 2002 Contribution of birth defects to infant mortality in the United States Teratology 66 Suppl 1 S3 S6 10.1002/tera.90002 12239736
2. PW Yoon RS Olney MJ Khoury WM Sappenfield GF Chavez D Taylor 1997 ontribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study Arch Pediatr Adolesc Med 151 11 1096 103 1:STN:280:DyaK1c%2Fjs1Kisg%3D%3D 9369870
3. Cunningham GF, Leveno KL, Bloom SL, Hauth JC, Gilstrap LC, Williams KDW. Obstetrics, 22nd Edition. 22nd ed. New York: McGraw-Hill Professional; 2005:1600.
4. RK Jones MR Zolna SK Henshaw LB Finer 2008 Abortion in the United States: incidence and access to services, 2005 Perspect Sex Reprod Health 40 1 6 16 10.1363/4000608 18318867
5. EB Schwarz J Maselli M Norton R Gonzales 2005 Prescription of teratogenic medications in United States ambulatory practices Am J Med 118 11 1240 1249 10.1016/j.amjmed.2005.02.029 16271908 (Pubitemid 41566525)
6. EB Schwarz DA Postlethwaite YY Hung MA Armstrong 2007 Documentation of contraception and pregnancy when prescribing potentially teratogenic medications for reproductive-age women Ann Intern Med 147 6 370 376 17876020
7. SE Andrade JH Gurwitz RL Davis, et al. 2004 Prescription drug use in pregnancy Am J Obstet Gynecol 191 2 398 407 10.1016/j.ajog.2004.04.025 15343213 (Pubitemid 39178690)
8. E Lee MK Maneno L Smith, et al. 2006 National patterns of medication use during pregnancy Pharmacoepidemiol Drug Saf 15 8 537 545 10.1002/pds.1241 16700083 (Pubitemid 44336268)
9. SE Andrade MA Raebel AN Morse, et al. 2006 Use of prescription medications with a potential for fetal harm among pregnant women Pharmacoepidemiol Drug Saf 15 8 546 554 10.1002/pds.1235 16586470 (Pubitemid 44336269)
10. JB VanGeest TP Johnson VL Welch 2007 Methodologies for improving response rates in surveys of physicians: a systematic review Eval Health Prof 30 4 303 321 10.1177/0163278707307899 17986667
11. Clinical Pharmacology. Gold Standard, Inc., Tampa, FL; 2009. www.jgim.org ) was developed with experts in survey design and methodology. Specialists in the fields of contraception, pharmacology, teratology and primary care internal medicine assisted with the content and assessed the survey for face validity. It was then pretested among members of the internal medicine department at our institution, modified to reflect suggested changes from these reviewers, and then it was transferred to an electronic format using a web-based survey service http://www.clinicalpharmacology.com. Accessed November 20, 2009.
12. J Trussell 2004 Contraceptive failure in the United States Contraception 70 2 89 96 10.1016/j.contraception.2004.03.009 15288211 (Pubitemid 38993483)
13. EA Akl N Maroun RA Klocke V Montori HJ Schunemann 2005 Electronic mail was not better than postal mail for surveying residents and faculty J Clin Epidemiol 58 4 425 429 10.1016/j.jclinepi.2004.10.006 15862729 (Pubitemid 40601993)
14. KK Boyer JR Olson R Calantone J Jackson 2002 Print versus electronic surveys: a comparison of two data collection methodologies J Oper Manag 20 Issue 4 357 373 10.1016/S0272-6963(02)00004-9 (Pubitemid 34716030)
15. CS Weisman DS Maccannon JT Henderson E Shortridge CL Orso 2002 Contraceptive counseling in managed care: preventing unintended pregnancy in adults Womens Health Issues 12 2 79 95 10.1016/S1049-3867(01)00147-5 11879761 (Pubitemid 34168526)
16. DW Bates 2007 Preventing medication errors: a summary Am J Health Syst Pharm 64 14 Suppl 9 S3 S9 10.2146/ajhp070190 17617512 quiz S24-26 (Pubitemid 47077119)
17. B Chaudhry J Wang S Wu, et al. 2006 Systematic review: impact of health information technology on quality, efficiency, and costs of medical care Ann Intern Med 144 10 742 752 16702590
18. R El-Kareh TK Gandhi EG Poon, et al. 2009 Trends in primary care clinician perceptions of a new electronic health record J Gen Intern Med 24 4 464 468 10.1007/s11606-009-0906-z 19156468
19. FDA. Pregnant Women to Benefit from Better Information. FDA Consumer Health Information [2008; http://www.fda.gov/downloads/ForConsumers/ ConsumerUpdates/UCM143746.pdf Accessed November 20, 2009.
20. MA Honein JA Lindstrom SL Kweder 2007 Can we ensure the safe use of known human teratogens?: The iPLEDGE test case Drug Saf 30 1 5 15 10.2165/00002018-200730010-00002 1:CAS:528:DC%2BD2sXitVams7c%3D 17194167
21. CT Lagoy N Joshi JD Cragan SA Rasmussen 2005 Medication use during pregnancy and lactation: an urgent call for public health action J Womens Health (Larchmt) 14 2 104 109 10.1089/jwh.2005.14.104 (Pubitemid 40567987)
22. Code of Federal Regulations, Title 21, Vol 4, 21 CFR201.57; 2001.
23. Physicians Desk Reference, 57th edition. Montvale, NJ: Thomson PDR; 2004.
24. Teratology public affairs committee position paper: pregnancy labeling for prescription drugs: ten years later. Birth Defects Res A Clin Mol Teratol. 2007;79(9):627-30.
25. CS Buhimschi CP Weiner 2009 Medications in pregnancy and lactation: part 1. Teratology Obstet Gynecol 113 1 166 188 19104374
26. CS Buhimschi CP Weiner 2009 Medications in pregnancy and lactation: part 2. Drugs with minimal or unknown human teratogenic effect Obstet Gynecol 113 2 Pt 1 417 432 19155916
27. Trussell J. Contraceptive efficacy. In: Hatcher RA, Trussel J, Stewart F, et al., eds. Contraceptive Technology Eighteenth revised edition. New York: Ardent Media; 2004.